Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen

Johannes R. Madsen, Jacob P. S. Nielsen, Kamille Fogh, Cecilie B. Hansen, Pernille B. Nielsen, Theis Lange, Rasmus B. Hasselbalch, Peter Garred, Kasper Iversen
doi: https://doi.org/10.1101/2021.02.09.21251421
Johannes R. Madsen
1Department of Emergency Medicine, Herlev-Gentofte Hospital, Copenhagen Denmark
2Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: johannes.roth.madsen.01@regionh.dk
Jacob P. S. Nielsen
1Department of Emergency Medicine, Herlev-Gentofte Hospital, Copenhagen Denmark
2Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jacob.pohl.stangerup.nielsen.01@regionh.dk
Kamille Fogh
1Department of Emergency Medicine, Herlev-Gentofte Hospital, Copenhagen Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cecilie B. Hansen
2Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pernille B. Nielsen
1Department of Emergency Medicine, Herlev-Gentofte Hospital, Copenhagen Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Theis Lange
3Section of Biostatistics, Department of Public Health, University of Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rasmus B. Hasselbalch
1Department of Emergency Medicine, Herlev-Gentofte Hospital, Copenhagen Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Garred
2Laboratory of Molecular Medicine, Department of Clinical Immunology, Section 7631, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kasper Iversen
1Department of Emergency Medicine, Herlev-Gentofte Hospital, Copenhagen Denmark
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Healthcare workers are at a higher risk of getting infected with SARS-CoV-2 than the general population. However, detailed knowledge about medical students and exposure to SARS-CoV-2 is lacking. Thus, we measured the prevalence of SARS-CoV-2 antibodies in a cohort of Danish medical students.

Methods We invited all medical students at the University of Copenhagen (UCPH) to participate. A venous blood sample was drawn along with completing a self-report questionnaire. Blood samples were analyzed for total antibodies to SARS-CoV-2 and related to symptomatology, social behaviour, and work-life. Seropositive samples were screened for IgM, IgG, and IgA antibodies.

Results Between October 19th and 26th 1,120 students participated in questionnaire, of these 1,096 were included in the study. Of all included 379 (34.58%) of the participants were seropositive. The risk of seropositivity was significantly increased for participants attending two parties at UCPH, on February the 29th and March 6th 2020 (OR 5.96 (95% CI 4.34-8.24, p<0.001). Further, 461 students (42.06%) worked with COVID-19 patients, which was significantly associated with risk of seropositivity (OR 1.38, 95% CI 1.03-1.85, p=0.033). The symptom most substantially associated with seropositivity was loss of smell and/or taste (n=183 of all, 31.35%) with an OR of 24.48 (95% CI 15.49-40.60, p<0.001).

Conclusion Medical students have the highest reported seropositivity in the Danish healthcare system. The risk of SARS-CoV-2 transmission amongst the students appear to be partly related to working with COVID-19 infected patients, but to a greater extent, their social behaviour.

Mainpoints Medical students have the highest reported seropositivity in the Danish healthcare system. The risk of SARS-CoV-2 transmission amongst the students appear to be partly related to working with COVID-19 infected patients, but to a greater extent, their social behaviour.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by grants from the Carlsberg Foundation [CF20-476 0045]; The Novo Nordisk Foundation [NFF205A0063505 and NNF20SA0064201] and the Union of Danish medical students (FADL). The funders did not influence study design, conduct or reporting.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study complied with the Declaration of Helsinki II and was approved by the regional ethics committee of the Capital Region (H-20055767) and by the Danish Data Protection Authorities (P-2020-92). Following the guidelines for the provision of oral and written information, all patients gave written informed consent to participate in the study.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

No data are available

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 12, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen
Johannes R. Madsen, Jacob P. S. Nielsen, Kamille Fogh, Cecilie B. Hansen, Pernille B. Nielsen, Theis Lange, Rasmus B. Hasselbalch, Peter Garred, Kasper Iversen
medRxiv 2021.02.09.21251421; doi: https://doi.org/10.1101/2021.02.09.21251421
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Anti-SARS-CoV-2 seropositivity among medical students in Copenhagen
Johannes R. Madsen, Jacob P. S. Nielsen, Kamille Fogh, Cecilie B. Hansen, Pernille B. Nielsen, Theis Lange, Rasmus B. Hasselbalch, Peter Garred, Kasper Iversen
medRxiv 2021.02.09.21251421; doi: https://doi.org/10.1101/2021.02.09.21251421

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (51)
  • Cardiovascular Medicine (453)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (158)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (191)
  • Epidemiology (5270)
  • Forensic Medicine (3)
  • Gastroenterology (196)
  • Genetic and Genomic Medicine (759)
  • Geriatric Medicine (80)
  • Health Economics (213)
  • Health Informatics (700)
  • Health Policy (361)
  • Health Systems and Quality Improvement (224)
  • Hematology (99)
  • HIV/AIDS (164)
  • Infectious Diseases (except HIV/AIDS) (5890)
  • Intensive Care and Critical Care Medicine (363)
  • Medical Education (105)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (767)
  • Nursing (43)
  • Nutrition (131)
  • Obstetrics and Gynecology (144)
  • Occupational and Environmental Health (234)
  • Oncology (480)
  • Ophthalmology (152)
  • Orthopedics (39)
  • Otolaryngology (95)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (98)
  • Psychiatry and Clinical Psychology (865)
  • Public and Global Health (2023)
  • Radiology and Imaging (349)
  • Rehabilitation Medicine and Physical Therapy (158)
  • Respiratory Medicine (287)
  • Rheumatology (94)
  • Sexual and Reproductive Health (74)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)